<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="spleen-strengthening, phlegm-dispelling, and blood-nourishing Fufang in the treatment of coronary" exact="heart disease" post="(CHD). The composition of Fufang was identified, followed by"/>
 <result pre="huge economic burden on the healthcare and society [1]. Coronary" exact="heart disease" post="(CHD) is the most common cardiovascular disease, characterized by"/>
 <result pre="society [1]. Coronary heart disease (CHD) is the most common" exact="cardiovascular disease," post="characterized by the formation of atherosclerotic plaques [2]. Risk"/>
 <result pre="of cardiovascular diseases, including venous thromboembolism, CHD, and incident ischemic" exact="heart disease" post="[33]. Chien et al. indicated that low levels of"/>
 <result pre="been reported to enhance T-cell activation [37], inhibit autophagy of" exact="hepatocellular carcinoma" post="cells [38], and enhance the secretion of adiponectin in"/>
 <result pre="have been reported to promote HDL-mediated cholesterol efflux and improve" exact="atherosclerosis" post="[45, 46]. In this study, CYP1A1, CYP1A2, APOA1, and"/>
 <result pre="11110.1007/s11886-017-0919-x 5GongP.LiY.YaoC.et al.Traditional Chinese medicine on the treatment of coronary" exact="heart disease" post="in recent 20 yearsJournal of Alternative and Complementary Medicine201723965966610.1089/acm.2016.042028497986"/>
 <result pre="20 yearsJournal of Alternative and Complementary Medicine201723965966610.1089/acm.2016.042028497986 6WangC.NiimiM.WatanabeT.et al.Treatment of" exact="atherosclerosis" post="by traditional Chinese medicine: questions and quandariesAtherosclerosis201827713614410.1016/j.atherosclerosis.2018.08.03930212682 7ZhangJ.MengH.ZhangY.et al.The"/>
 <result pre="Pharmaceutical Design201723345086509610.2174/138161282366617080310160228782475 8ChenR.XiaoY.ChenM.et al.A traditional Chinese medicine therapy for coronary" exact="heart disease" post="after percutaneous coronary intervention: a meta-analysis of randomized, double-blind,"/>
 <result pre="36210.3390/biom9080362 25RenL.ZhengX.LiuJ.et al.Network pharmacology study of traditional Chinese medicines for" exact="stroke" post="treatment and effective constituents screeningJournal of Ethnopharmacology201924210.1016/j.jep.2019.112044 26NiuB.ZhangH.LiC.et al.Network"/>
 <result pre="A.JohanssonM. E.BergstrÃ¶mG. M.Social disruption stress increases IL-6 levels and accelerates" exact="atherosclerosis" post="in ApoEâˆ’/âˆ’ miceAtherosclerosis2011221235936510.1016/j.atherosclerosis.2011.11.04122284955 29DaneshJ.KaptogeS.MannA. G.et al.Long-term interleukin-6 levels and"/>
 <result pre="al.Albumin: pathophysiologic basis of its role in the treatment of" exact="cirrhosis" post="and its complicationsHepatology20135851836184610.1002/hep.2633823423799 33ArquesS.Human serum albumin in cardiovascular diseasesEuropean"/>
 <result pre="tyrosine phosphatase activityActa Pharmacologica Sinica201334452253010.1038/aps.2012.20823524573 38WangM.HuangC.SuY.et al.Astragaloside II sensitizes human" exact="hepatocellular carcinoma" post="cells to 5-fluorouracil via suppression of autophagyJournal of Pharmacy"/>
 <result pre="al.Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via" exact="suppression" post="of autophagyJournal of Pharmacy and Pharmacology201769674375210.1111/jphp.1270628266023 39XuA.WangH.HooR. L.et al.Selective"/>
 <result pre="compounds derived from a medicinal herb alleviates insulin resistance and" exact="glucose intolerance" post="in obese miceEndocrinology2009150262563310.1210/en.2008-099918927219 40WangH. H.GarrutiG.LiuM.PortincasaP.WangD. Q.Cholesterol and lipoprotein metabolism"/>
</results>
